Sellas Life Sciences Group Inc (RXK3) Stock Price & News

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	4.22M	4.73M	5.13M	6.27M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	2.87M	2.42M	4.12M	3.36M
Operating expense	7.08M	7.16M	9.25M	9.63M
Total operating expenses	7.08M	7.16M	9.25M	9.63M
Operating income	-7.08M	-7.16M	-9.25M	-9.63M
Other non operating income	-	-	-	-
EBT including unusual items	-6.79M	-7.66M	-8.41M	-9.60M
EBT excluding unusual items	-6.79M	-6.56M	-8.41M	-8.60M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-6.79M	-7.66M	-8.41M	-9.60M
Net profit margin	-	-	-	-
Earnings per share	-0.06	-0.05	-0.05	-0.05
Interest and investment income	292.00K	597.00K	845.00K	1.02M
Interest expense	-	-	-	-
Net interest expenses	292.00K	597.00K	845.00K	1.02M
Depreciation and amortization charges	-	-	-	-
EBITDA	-	-	-	-
Gain or loss from assets sale	-	-	-	-

Finance